Bambi Tablets 10mg | Antiasthmatic & COPD Preparations | Pharmaceuticals | Products

Bambi Tablets 10mg

Code:

DRPS0252B

Active Ingredient:

Bambuterol HCI 10mg

Description:

White color round corner rectangular shaped film coated tablet, engraved "MK" on one side.

Regulatory Class:

P1
Prescription Drug

HK-67027

Indication
Indication
Use and Administration

Indication

Use and Administration

Management of asthma, bronchospasm and/ or reversible airways obstruction.

Posology
Bambi is formulated as a tablet and should be taken once daily, shortly before bedtime.

Patients must receive optimal anti-inflammatory therapy (e.g. inhaled corticosteroids, leukotriene receptor antagonists) when using Bambi for management of asthma.

Adults

The recommended starting doses are 10 mg–20 mg. The 10 mg dose may be increased to 20 mg if necessary after 1–2 weeks, depending on the clinical effect.

In patients who have previously tolerated β2-agonists well, the recommended starting dose, as well as maintenance dose, is 20 mg.